BridgeBio Pharma Inc

NASDAQ:BBIO   12:34:33 PM EDT
49.40
+0.47 (+0.96%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)7.40B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$18.78 Million
Adjusted EPS-$0.87
See more estimates
10-Day MA$48.09
50-Day MA$48.72
200-Day MA$57.18
See more pivots

BridgeBio Pharma Inc Stock, NASDAQ:BBIO

421 Kipling Street, Palo Alto, California 94301
United States of America
Phone: +1.650.391.9740
Number of Employees: 385

Description

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Frank McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.